Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
58.83B | 69.08B | 126.09B | 69.14B | 37.10B | Gross Profit |
22.87B | 22.45B | 28.93B | 16.03B | 11.32B | EBIT |
6.17B | -17.85B | 19.77B | 8.04B | 9.01B | EBITDA |
16.84B | -7.70B | 25.63B | 21.24B | 15.59B | Net Income Common Stockholders |
-206.00M | -20.51B | 15.13B | 10.96B | 15.60B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
32.94B | 39.18B | 38.13B | 14.83B | 29.87B | Total Assets |
298.79B | 281.14B | 314.14B | 270.38B | 196.72B | Total Debt |
96.62B | 88.05B | 71.55B | 58.53B | 41.82B | Net Debt |
73.81B | 78.38B | 57.84B | 49.90B | 36.38B | Total Liabilities |
205.30B | 203.34B | 218.61B | 185.25B | 99.39B | Stockholders Equity |
83.09B | 75.89B | 91.54B | 82.06B | 94.61B |
Cash Flow | Free Cash Flow | |||
-24.30B | -9.67B | -21.08B | -22.42B | -10.49B | Operating Cash Flow |
18.36B | 28.53B | 11.92B | 12.15B | 16.47B | Investing Cash Flow |
-21.76B | -34.73B | -17.91B | -12.59B | -16.56B | Financing Cash Flow |
15.84B | 265.00M | 13.79B | 3.39B | -2.13B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | $92.54B | 20.95 | 9.10% | 3.49% | 4.46% | 54.09% | |
74 Outperform | $38.06B | 20.57 | 8.44% | 3.10% | 4.23% | -27.02% | |
73 Outperform | $56.05B | 18.82 | 11.37% | 3.47% | 2.76% | 31.53% | |
71 Outperform | $144.14B | 21.01 | 14.24% | 2.98% | 26.91% | -6.43% | |
65 Neutral | $12.12B | 15.70 | 7.09% | 4.31% | 5.53% | -2.84% | |
64 Neutral | $45.77B | 15.75 | 9.55% | 3.57% | -18.00% | -7.54% | |
52 Neutral | $19.94B | 21.10 | -1.25% | ― | -14.89% | 96.53% |